… Casirivimab/imdevimab (Ronapreve™; REGEN-COV™) is a co-packaged combination of two neutralizing immunoglobulin gamma 1 (IgG1) human monoclonal antibodies (casirivimab …
S Deresinski - Infectious Disease Alert, 2021 - search.proquest.com
… O’Brien and colleagues examined the efficacy of REGEN-COV administration as post-… of SARS-CoV-2-infected individuals. REGEN-COV is a combination of two monoclonal antibodies, …
… REGEN-COV, the cocktail of monoclonal antibodies casirivimab and imdevimab, was given Emergency Use Authorization (EUA) for the treatment of patients with mild-moderate COVID-…
A Shimizu, I Shirai, K Ogawa, A Miura, K Haruhara… - Internal …, 2022 - jstage.jst.go.jp
… and imdevimab (REGEN-COV) monoclonal antibodies in combination with remdesivir resulted … The REGEN-COVantibody cocktail may improve the outcome of SARS-CoV-2 infection in …
… In vitro, a combination of casirivimab and imdevimab induced antibody-mediated … baseline antibody status were randomly assigned to receive usual treatment with REGEN-COV or …
S Liu, Y Yan, CM Secor, ZR Oberholtzer, DJ Skow… - Mabs, 2024 - Taylor & Francis
… antibodies. These results suggest that the presence of heterodimers in co-formulated REGEN-COV Ⓡ … Citation17 This combination of SEC and HIC has been demonstrated to enable …
R Menéndez, P Gonzalez, A Latorre… - Revista Española de …, 2022 - ncbi.nlm.nih.gov
… [10] in hospitalized patients treated with REGEN-COV2 versus … REGEN-COV2 combination antibody therapy showed … have not developed an antibody response to SARS-CoV-2 infection…
Y Shimamura, T Maeda, N Moniwa, H Takizawa - 2022 - europepmc.org
… monoclonal antibodycombination of casirivimab and imdevimab (REGEN-COV) has been … This report highlights the importance of the early use of REGEN-COV in patients with COVID…
C Boggiano, RW Eisinger, AM Lerner… - Annals of internal …, 2022 - acpjournals.org
… The REGEN-COV trials assessed the mAb combination casirivimab–imdevimab delivered intravenously in outpatients. The phase 2 trial showed that participants who were …